Biochemistry Department, Hôpital Bicêtre, APHP Université Paris-Saclay, Le Kremlin Bicêtre F-94275, France; Université Paris-Saclay, CNRS, Institut de Chimie des Substances Naturelles, UPR 2301, 91198 Gif-sur-Yvette, France.
Pediatric Neurology Department, Hôpital Necker Enfants Malades, Institut Imagine, APHP Centre - Université de Paris, Paris F-75015, France.
Mitochondrion. 2020 May;52:75-82. doi: 10.1016/j.mito.2020.02.008. Epub 2020 Feb 21.
We report a patient carrying a novel pathogenic variant p.(Tyr101Cys) in ISCA1 leading to MMDS type 5. He initially presented a psychomotor regression with loss of gait and language skills and a tetrapyramidal spastic syndrome. Biochemical analysis of patient fibroblasts revealed impaired lipoic acid synthesis and decreased activities of complex I and II of respiratory chain. While ISCA1 is involved in the mitochondrial machinery for iron-sulfur cluster biogenesis, these dysfunctions are secondary to impaired maturation of mitochondrial proteins containing the [4Fe-4S] clusters. Expression and purification of the human ISCA1 showed a decreased stability of the [2Fe-2S] cluster in the mutated protein.
我们报告了一例携带 ISCA1 中新型致病性变异 p.(Tyr101Cys) 的患者,导致 MMDS 型 5。他最初表现为精神运动倒退,伴有步态和语言技能丧失以及四肢痉挛性瘫痪综合征。对患者成纤维细胞的生化分析显示脂酰辅酶 A 合成受损,呼吸链复合物 I 和 II 的活性降低。虽然 ISCA1 参与线粒体铁硫簇生物发生的机制,但这些功能障碍是由于含有 [4Fe-4S] 簇的线粒体蛋白成熟受损引起的。人 ISCA1 的表达和纯化显示突变蛋白中 [2Fe-2S] 簇的稳定性降低。